106 related articles for article (PubMed ID: 1551314)
1. Increased hypothalamic neuropeptide Y messenger RNA levels in two rat models of diabetes.
Jones PM; Pierson AM; Williams G; Ghatei MA; Bloom SR
Diabet Med; 1992; 9(1):76-80. PubMed ID: 1551314
[TBL] [Abstract][Full Text] [Related]
2. Elevated neuropeptide Y concentrations in the central hypothalamus of the spontaneously diabetic BB/E Wistar rat.
Williams G; Lee YC; Ghatei MA; Cardoso HM; Ball JA; Bone AJ; Baird JD; Bloom SR
Diabet Med; 1989; 6(7):601-7. PubMed ID: 2527701
[TBL] [Abstract][Full Text] [Related]
3. Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus.
Marks JL; Waite K; Li M
Diabetologia; 1993 Jun; 36(6):497-502. PubMed ID: 8335171
[TBL] [Abstract][Full Text] [Related]
4. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
White JD; Olchovsky D; Kershaw M; Berelowitz M
Endocrinology; 1990 Feb; 126(2):765-72. PubMed ID: 2404748
[TBL] [Abstract][Full Text] [Related]
5. Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats - in vitro and in vivo studies of transmitter release.
Gozali M; Pavia JM; Morris MJ
Diabetologia; 2002 Sep; 45(9):1332-9. PubMed ID: 12242467
[TBL] [Abstract][Full Text] [Related]
6. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids.
Dryden S; Burns SJ; Frankish HM; Williams G
Eur J Pharmacol; 1997 Dec; 340(2-3):221-5. PubMed ID: 9537819
[TBL] [Abstract][Full Text] [Related]
7. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
Hidaka S; Yoshimatsu H; Kondou S; Oka K; Tsuruta Y; Sakino H; Itateyama E; Noguchi H; Himeno K; Okamoto K; Teshima Y; Okeda T; Sakata T
J Neurochem; 2001 May; 77(4):993-1000. PubMed ID: 11359864
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
Sindelar DK; Mystkowski P; Marsh DJ; Palmiter RD; Schwartz MW
Diabetes; 2002 Mar; 51(3):778-83. PubMed ID: 11872679
[TBL] [Abstract][Full Text] [Related]
9. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Liu IM; Chi TC; Cheng JT
Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats.
Fu M; Li X; Zhang M; Xian Y
Chin Med J (Engl); 2002 May; 115(5):690-5. PubMed ID: 12133536
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
Sahu A; Sninsky CA; Kalra PS; Kalra SP
Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
[TBL] [Abstract][Full Text] [Related]
12. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression.
Sipols AJ; Baskin DG; Schwartz MW
Diabetes; 1995 Feb; 44(2):147-51. PubMed ID: 7859932
[TBL] [Abstract][Full Text] [Related]
13. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.
Mizuno TM; Makimura H; Silverstein J; Roberts JL; Lopingco T; Mobbs CV
Endocrinology; 1999 Oct; 140(10):4551-7. PubMed ID: 10499510
[TBL] [Abstract][Full Text] [Related]
14. Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to insulin-dependent diabetes and voluntary lard ingestion.
la Fleur SE; Manalo SL; Roy M; Houshyar H; Dallman MF
Eur J Neurosci; 2005 May; 21(10):2733-42. PubMed ID: 15926921
[TBL] [Abstract][Full Text] [Related]
15. Role of glucocorticoids in mediating effects of fasting and diabetes on hypothalamic gene expression.
Makimura H; Mizuno TM; Isoda F; Beasley J; Silverstein JH; Mobbs CV
BMC Physiol; 2003 Jul; 3():5. PubMed ID: 12848900
[TBL] [Abstract][Full Text] [Related]
16. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes.
Chavez M; Seeley RJ; Havel PJ; Friedman MI; Matson CA; Woods SC; Schwartz MW
J Clin Invest; 1998 Jul; 102(2):340-6. PubMed ID: 9664075
[TBL] [Abstract][Full Text] [Related]
17. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.
Havel PJ; Hahn TM; Sindelar DK; Baskin DG; Dallman MF; Weigle DS; Schwartz MW
Diabetes; 2000 Feb; 49(2):244-52. PubMed ID: 10868941
[TBL] [Abstract][Full Text] [Related]
18. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats.
Abe M; Saito M; Ikeda H; Shimazu T
Brain Res; 1991 Jan; 539(2):223-7. PubMed ID: 2054597
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model.
Campos EJ; Martins J; Brudzewsky D; Woldbye DPD; Ambrósio AF
Ann Anat; 2020 Jan; 227():151419. PubMed ID: 31563570
[TBL] [Abstract][Full Text] [Related]
20. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]